One year in review
One year in review 2018: psoriatic arthritis
E. Calabresi1, S. Monti2, G. Governato3, L. Carli4
- Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
- University of Pavia, Department of Rheumatology, IRCCS Policlinico S. Matteo Foundation, and University of Pavia, PhD in Experimental Medicine, Pavia, Italy
- Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
- Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy. 81clinda@gmail.com
CER12208
2019 Vol.37, N°2
PI 0167, PF 0178
One year in review
Free to view
(click on article PDF icon to read the article)
PMID: 30900548 [PubMed]
Received: 04/03/2019
Accepted : 14/03/2019
In Press: 19/03/2019
Published: 19/03/2019
Abstract
Spondyloarthritis (SpA) is an inflammatory condition characterised by a broad spectrum of clinical manifestations, laboratory abnormalities and imaging features that genetically tend to be associated with the major histocompatibility complex class 1 antigen, HLA-B27, and in which both peripheral and axial joints might be affected. In addition to arthritis, the typical musculoskeletal manifestations are enthesitis and dactylitis. Extraarticular manifestations such as acute anterior uveitis (AAU), psoriasis (PsO) and inflammatory bowel disease (IBD) are also typical of SpA. In this article we have reviewed the literature of the past year on one of the most important variants of SpA, i.e. psoriatic arthritis (PsA) (Medline search of articles published from 1st January 2018 to 31st January 2019).
